---
schema_version: "secwatch.filing_event.v1"
accession: "0001793229-26-000077"
form_type: "8-K"
ticker: "CTEV"
cik: "0001793229"
company_name: "Claritev Corp"
filed_at: "2026-10-15T13:03:37+00:00"
generated_at: "2026-10-15T13:05:03.557055+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Claritev adds Jennifer Main to board; ex-CMS COO and TARP CFO takes new Class II seat

## Summary
- Board expanded from 11 to 12 directors; Main appointed to the newly created Class II directorship effective October 15, 2026, and joins the Audit Committee.
- Concurrently, Mr. Jason Kap ceased serving as a member of the Audit Committee; no other committee changes disclosed.
- Main is CFO of RealMDai (dba Certuma) and Overture Life since March 2026; previously CFO and COO of Amalgam Rx from 2021 to 2026.
- She was Chief Operating Officer of the Centers for Medicare & Medicaid Services from 2018 to 2021, overseeing Medicare, Medicaid and marketplace programs, and CFO of Treasury's $700 billion TARP.
- Compensation follows the non-employee director policy in the March 20, 2026 proxy; she will enter the company's standard indemnification agreement. No related-party transactions disclosed.

## SEC filing metadata
- accession: 0001793229-26-000077
- form_type: 8-K
- ticker: CTEV
- cik: 0001793229
- company_name: Claritev Corp
- filed_at: 2026-10-15T13:03:37+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1793229/000179322926000077/0001793229-26-000077-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1793229/000179322926000077/ctev-20261015.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001793229-26-000077
- JSON: https://secwatch.observer/filing/0001793229-26-000077.json
- Plain text: https://secwatch.observer/filing/0001793229-26-000077.txt

## Key facts
- Executive change
  Jennifer Main was appointed as Class II director at Claritev Corp.
  - Action: appointed
  - Role: Class II director
  source text: Effective as of the Effective Date, the Board appointed Ms. Jennifer Main to fill the newly created directorship, to serve as a Class II director and a member of the Audit Committee.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1793229/000179322926000077/0001793229-26-000077-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.